Evidence map›Paper›PMID 27018585›Full record

ArticlePLoS neglected tropical diseases2016

Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax.

Lindsey R Friedrich, Jean Popovici, Saorin Kim, Lek Dysoley, Peter A Zimmerman, Didier Menard, David Serre

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Single-cell analyses of polyclonalResearch square · 2024
    Article
  11. Genetic diversity ofLancet regional health. Americas · 2023
    Article
  12. Article
  13. Dynamic Classification ofJournal of data science : JDS · 2022
    Article
  14. Novel highly-multiplexed AmpliSeq targeted assay forFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lindsey R FriedrichGenomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, United States of America.
Jean PopoviciUnite d'Epidemiologie Moleculaire, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Saorin KimUnite d'Epidemiologie Moleculaire, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Lek DysoleyNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Peter A ZimmermanCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, United States of America.
Didier MenardUnite d'Epidemiologie Moleculaire, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
David SerreGenomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, United States of America.
Cleveland Clinic Lerner College of Medicine · USCambodia National Malaria Center · KHCase Western Reserve University · US

Funding

Madagascar P. vivax Invasion of Duffy-negative Red CellsR01AI097366 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2013 to 2017
$3.6M
Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in CambodiaR01AI103228 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SERRE, DAVID · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI097366NIAID NIH HHS R01 AI103228PHS HHS R01 A103328
6 · The paper itself

Abstract

backgroundPlasmodium vivax is the most widely distributed human malaria parasite with 2.9 billion people living in endemic areas. Despite intensive malaria control efforts, the proportion of cases attributed to P. vivax is increasing in many countries. Genetic analyses of the parasite population and its dynamics could provide an assessment of the efficacy of control efforts, but, unfortunately, these studies are limited in P. vivax by the lack of informative markers and high-throughput genotyping methods. METHODOLOGY/PRINCIPAL

findingsWe developed a sequencing-based assay to simultaneously genotype more than 100 SNPs and applied this approach to ~500 P. vivax-infected individuals recruited across nine locations in Cambodia between 2004 and 2013. Our analyses showed that the vast majority of infections are polyclonal (92%) and that P. vivax displays high genetic diversity in Cambodia without apparent geographic stratification. Interestingly, our analyses also revealed that the proportion of monoclonal infections significantly increased between 2004 and 2013, possibly suggesting that malaria control strategies in Cambodia may be successfully affecting the parasite population. CONCLUSIONS/SIGNIFICANCE: Our findings demonstrate that this high-throughput genotyping assay is efficient in characterizing P. vivax diversity and can provide valuable insights to assess the efficacy of malaria elimination programs or to monitor the spread of specific parasites.

Indexed as

Polymorphism, Single NucleotideCambodiaDNA, ProtozoanFemaleGenetic MarkersGenotypeHumansMalaria, VivaxMalePlasmodium vivaxDNA, ProtozoanGenetic Markers

Identifiers

PMID27018585
PMCPMC4809505
OpenAlexW2315116899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.